Data & Insights 1 min read

Orbisa ON Intercept Pharma

Orbisa ON Intercept Pharma
Share

Orbisa provides robust metrics for the buy-side allowing market participants to validate their short positions. In our latest analytical piece, Orbisa insights shows a striking decline in borrowing demand for Intercept Pharmaceuticals. 

Published October 20, 2022.

Connecting
Securities Finance

Stay ahead in securities finance with expert insights, market trends, and timely updates.

By subscribing, you agree to our Privacy Policy.